Spatiotemporally deciphering the mysterious mechanism of persistent HPV‐induced malignant transition and immune remodelling from HPV‐infected normal cervix, precancer to cervical cancer: Integrating single‐cell RNA‐sequencing and spatial transcriptome
Top Cited Papers
Open Access
- 26 March 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (3) , e1219
Abstract
Background: The mechanism underlying cervical carcinogenesis that is mediated by persistent human papillomavirus (HPV) infection remains elusive.Aims: Here, for the first time, we deciphered both the temporal transition and spatial distribution of cellular subsets during disease progression from normal cervix tissues to precursor lesions to cervical cancer.Materials & Methods: We generated scRNA‐seq profiles and spatial transcriptomics data from nine patient samples, including two HPV‐negative normal, two HPV‐positive normal, two HPV‐positive HSIL and three HPV‐positive cancer samples.Results: We not only identified three ‘HPV‐related epithelial clusters’ that are unique to normal, high‐grade squamous intraepithelial lesions (HSIL) and cervical cancer tissues but also discovered node genes that potentially regulate disease progression. Moreover, we observed the gradual transition of multiple immune cells that exhibited positive immune responses, followed by dysregulation and exhaustion, and ultimately established an immune‐suppressive microenvironment during the malignant program. In addition, analysis of cellular interactions further verified that a ‘homeostasis‐balance‐malignancy’ change occurred within the cervical microenvironment during disease progression.Discussion: We for the first time presented a spatiotemporal atlas that systematically described the cellular heterogeneity and spatial map along the four developmental steps of HPV‐related cervical oncogenesis, including normal, HPV‐positive normal, HSIL and cancer. We identified three unique HPV‐related clusters, discovered critical node genes that determined the cell fate and uncovered the immune remodeling during disease escalation.Conclusion: Together, these findings provided novel possibilities for accurate diagnosis, precise treatment and prognosis evaluation of patients with precancer and cervical cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81971361, 82173188)
This publication has 58 references indexed in Scilit:
- HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cellsInternational Journal of Cancer, 2014
- Cadherin 17 is a Novel Diagnostic Marker for Adenocarcinomas of the Digestive SystemAdvances in Anatomic Pathology, 2014
- Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathwaysCellular Signalling, 2014
- The CD46-Jagged1 interaction is critical for human TH1 immunityNature Immunology, 2012
- Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancerBreast Cancer Research and Treatment, 2011
- CD46 in innate and adaptive immunity: an updateClinical and Experimental Immunology, 2011
- Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesionsGynecologic Oncology, 2009
- SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporterLife Sciences, 2006
- Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particlesGynecologic Oncology, 2005
- Carcinoembryonic Antigen Family Members CEACAM6 and CEACAM7 Are Differentially Expressed in Normal Tissues and Oppositely Deregulated in Hyperplastic Colorectal Polyps and Early AdenomasThe American Journal of Pathology, 2000